ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $260,000 | -20.0% | 20,867 | -12.1% | 0.00% | 0.0% |
| Q3 2016 | $325,000 | +90.1% | 23,746 | +2.5% | 0.00% | +100.0% |
| Q2 2016 | $171,000 | -10.5% | 23,170 | -22.4% | 0.00% | -50.0% |
| Q1 2016 | $191,000 | -37.6% | 29,848 | -39.0% | 0.00% | -33.3% |
| Q4 2015 | $306,000 | +1.0% | 48,966 | -5.5% | 0.00% | 0.0% |
| Q3 2015 | $303,000 | -29.2% | 51,800 | +0.0% | 0.00% | -25.0% |
| Q2 2015 | $428,000 | +14.7% | 51,784 | +14.4% | 0.00% | 0.0% |
| Q1 2015 | $373,000 | +17.3% | 45,251 | -2.4% | 0.00% | 0.0% |
| Q4 2014 | $318,000 | +42.6% | 46,346 | +12.1% | 0.00% | +33.3% |
| Q3 2014 | $223,000 | +24.6% | 41,341 | +46.7% | 0.00% | 0.0% |
| Q2 2014 | $179,000 | -39.3% | 28,174 | -22.9% | 0.00% | -25.0% |
| Q1 2014 | $295,000 | +143.8% | 36,549 | +106.4% | 0.00% | +100.0% |
| Q4 2013 | $121,000 | – | 17,712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,331,100 | $23,281,000 | 8.28% |
| DAFNA Capital Management LLC | 191,215 | $3,344,000 | 4.89% |
| Redmile Group, LLC | 1,277,109 | $22,337,000 | 3.94% |
| BB BIOTECH AG | 3,115,371 | $54,488,000 | 3.92% |
| SECTORAL ASSET MANAGEMENT INC | 5,292,682 | $92,569,000 | 2.74% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 565,956 | $9,899,000 | 1.76% |
| OAK RIDGE INVESTMENTS LLC | 2,645,781 | $46,275,000 | 1.45% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,265,104 | $22,127,000 | 1.04% |
| Tekla Capital Management LLC | 412,965 | $7,223,000 | 0.98% |
| Private Capital Advisors, Inc. | 127,600 | $2,232,000 | 0.83% |